Latest news
Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMTBeOne Medicines (ONC) Stock Looks Strong On Returns But Above Fair Value - simplywall.stsimplywall.st · Sun, 09 Aug 2026 05:40:45 GMTHigh Risk, High Reward: Inside The Revolution Medicines Bull Case (NASDAQ:RVMD) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 08:19:34 GMTIronwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed? - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 04:31:00 GMTDoes New US Orphan Drug Status For Zoci Reshape The Bull Case For Zai Lab (ZLAB)? - simplywall.stsimplywall.st · Wed, 05 Aug 2026 20:41:09 GMTThe Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone - simplywall.stsimplywall.st · Mon, 03 Aug 2026 03:15:17 GMTThe Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following Sharp EPS Estimate Cuts Amid Rising Sales - simplywall.stsimplywall.st · Sat, 01 Aug 2026 18:59:48 GMT